Newsroom
307 articles
FeaturedIn order to provide vital safety alerts, the U.S. Food and Drug Administration is warning patients about a safety issue with diabetic devices that rely on smartphones, including…
FeaturedNemolizumab, also known as Nemluvio, has been approved by the Medicines and Healthcare Products Regulatory Agency (MHRA) to treat moderate to severe prurigo nodularis in adults aged 18…
FeaturedThe Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of gozetotide (marketed under the name Illuccix) in a positioning emission tomography (PET) scan, a form…
FeaturedThe MHRA has authorized the chikungunya vaccine (live) (brand name IXCHIQ) to prevent adults from chikungunya disease, which is caused by the chikungunya virus (CHIKV). CHIKV is spread…
FeaturedThe Medicines and Healthcare Products Regulatory Agency (MHRA) has opened a consultation on regulatory guidance for personalized mRNA cancer immunotherapies (also known as cancer vaccines). This is a…
FeaturedThe EMA’s human medicines committee (CHMP) has issued a good scientific opinion on Ivermectin/Albendazole for the treatment of illnesses caused by a variety of worm parasites, including lymphatic…
FeaturedThe widespread use of azole fungicides (azoles), notably in some agricultural and horticultural operations, raises the possibility of Aspergillus fungus acquiring resistance to critical antifungal treatments. This noteworthy…
FeaturedThe FDA has approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid analgesic, to treat moderate to severe acute pain in adults. Journavx alleviates pain by inhibiting…
FeaturedThe Medicines and Healthcare Products Regulatory Agency (MHRA) has approved garadacimab (brand name Andembry) for the prevention of angioedema attacks in individuals aged 12 and up with hereditary…
FeaturedIf approved, the United States would be the world’s first government to adopt such a bold, life-saving step to prevent and decrease smoking-related disease and death. The FDA…
FeaturedExtra safety information is being added to all montelukast products, Montelukast is a prescription medicine used to prevent and treat chronic asthma in adults and children aged 2…
FeaturedNew approval by the Medicines and Healthcare products Regulatory Agency (MHRA) of the medicine sotatercept (Winrevair) to treat pulmonary arterial hypertension (PAH). Sotatercept is used, in combination with…
FeaturedThe Medicines and Healthcare Products Regulatory Agency (MHRA) has approved tarlatamab (Imdylltra) as a treatment for adult patients with small cell lung cancer (SCLC) that has progressed to…
FeaturedThe U.S. Food and Drug Administration issued a draft guidance with the Office for Human Research Protections that will offer suggestions for incorporating tissue biopsies into clinical trials…
FeaturedThe Medicines and Healthcare products Regulatory Agency (MHRA) has approved the conditional marketing authorization of givinostat (Duvyzat), a medication used to treat Duchenne muscular dystrophy (DMD). Givinostat is…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP